“…The majority of the determinants encompassed within these sites are recognized by CD4 þ and mouse MHC class II-restricted T cells; one was recognized by an MHC class I-restricted, cytotoxic T-cell (CTL) hybridoma (18); recently, four hTg peptides were described eliciting EAT in HLA-DR3-transgenic mice (21,26). Within the last group, of note are hTg peptides p2079, which elicits considerable EAT both directly and by adoptive transfer assays (21), and p2340 (23,26), which was originally shown to be a target of Tg-reactive Abs in patients with Graves' disease (27). To a large extent, these findings reflected the bias of the screening approach; for example, since susceptibility to EAT is A k controlled, computerized algorithms were used to search for A k -binding, pathogenic Tg peptides.…”